Cibus, Inc.
CBUS • NASDAQ
Cibus, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Peter R. Beetham, with a market cap of $143.2M.
CEOPeter R. Beetham
Next Earnings
Upcoming earnings announcement for Cibus, Inc.
Date
Thursday, May 7, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.20
Revenue Estimate
$1.5M
Earnings History
Past 11 earnings reports for Cibus, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 17, 2026 | Q4 2025 | -$0.42Est: -$0.26 | -61.5% | $1.1MEst: $1.6M | -32.9% | — |
| Nov 13, 2025 | Q3 2025 | -$0.44Est: -$0.27 | -63.0% | $615.0KEst: $1.3M | -51.6% |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.61Est: -$0.47 | -29.8% | $933.0KEst: $1.2M | -19.0% | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.74Est: -$0.36 | -105.6% | $1.0MEst: $1.2M | -10.1% | 10-Q |
| Mar 20, 2025 | Q4 2024 | -$0.87Est: -$0.76 | -14.5% | $1.2MEst: $1.1M | +7.3% | 10-K |
| Nov 7, 2024 | Q3 2024 | $0.06Est: -$0.89 | +106.7% | $1.7MEst: $610.0K | +173.3% | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$1.14Est: -$0.81 | -40.7% | $838.0KEst: $440.0K | +90.5% | 10-Q |
| May 9, 2024 | Q1 2024 | -$1.12Est: -$1.01 | -10.9% | $545.0KEst: $390.0K | +39.7% | 10-Q |
| Mar 21, 2024 | Q4 2023 | -$1.27Est: -$1.43 | +11.2% | $1.1MEst: $380.0K | +190.3% | 10-K |
| Nov 9, 2023 | Q3 2023 | -$1.59Est: -$1.17 | -35.9% | $475.0KEst: $270.0K | +75.9% | — |
| Aug 9, 2023 | Q2 2023 | -$3.05 | — | $197.0K | — | 10-Q |